Delivery Order SPE2DB22D3016-SPE2DB24FBDD0
Award Date
8/6/24
Potential Completion Date
8/7/24
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $26,523.78 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,991.18 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, with an ultimate completion date of October 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $6,852.76 firm-fixed-price contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This federal contract award is a delivery order valued at $10,500.77, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used to treat diabetes. The award has an ultimate completion date of August 27, 2024 and uses a firm fixed-price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $14,699.06 firm-fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,187.48 firm-fixed-price contract is for the supply of the diabetes medication OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The award has an ultimate completion date of August 12, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide essential pharmaceutical products to support military...
This federal contract award, with a ceiling value of $8,945.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication, to support federal healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of September 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug...
This federal contract award, valued at $21,009.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used in the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $37,727.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication. The contract is a delivery order that runs until May 9, 2024. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) valued at $5,959.91. The award is for the procurement of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product. The contract does not have a set-aside designation and has a period of performance through August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has multiple indefinite delivery contracts (IDCs) with various...